CRP and rheumatoid arthritis: Among the 43/104 D2T-RA patients identified at t0, we found that 19/43 (44.2%) had a moderate/high disease activity according to the SDAI score, 16/43 (37.2%) presented with an otherwise unexplained raised CRP value, and 26/43 (60.5%) were treated with glucocorticoid at a dosage of at least 7.5 mg day of prednisone equivalent.